Search - tctmd.com

Displaying 341 - 360 of 409

Sort: Relevancy | Date

News Daily News

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

August 23, 2012

News Daily News

Study Suggests Shortening Delay to Noncardiac Surgery After PCI

Yael L. Maxwell

August 17, 2012

News Industry News

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

August 08, 2012

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

News Daily News

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

June 01, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

May 18, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

May 16, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

May 15, 2012

News Daily News

Baseline Anemia Raises Risk for Stent Thrombosis After DES

April 04, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

March 26, 2012

News Conference News ACC 2012

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

March 26, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

March 25, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

March 25, 2012

A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial

Presentation ACC 2012

A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial

Presenter: Myeong-Ki Hong

March 25, 2012

News Conference News ACC 2012

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

March 24, 2012

News Conference News ACC 2012

Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation

March 24, 2012

News Daily News

Surgery Common, Safe After Coronary Stent Implantation

March 13, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

March 08, 2012

News Daily News

Study Finds No ‘Obesity Paradox’ in DES-Treated Patients

March 06, 2012

News Daily News

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Yael L. Maxwell

March 06, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.